Lidocaine Hydrochloride | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Lidocaine Hydrochloride
US Patents

PharmaCompass Sponsored Ads

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Lidocaine Hydrochloride

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Lidocaine Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

52 API Suppliers, 14 USDMF, 10 CEP/COS, 3 JDMF, 10 EU WC, 13 KDMF, 30 NDC API, 38 Listed Suppliers, $ API Reference Price

52 API Suppliers
14 USDMF
10 CEP/COS
3 JDMF
10 EU WC
13 KDMF
30 NDC API
38 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

5 Drugs in Development

5 Drugs in Development

FINISHED DOSAGE FORMULATIONS

409 FDF Dossiers, 226 FDA Orange Book, 67 Europe, 64 Canada, 15 South Africa, 37 Listed Dossiers

409 FDF Dossiers
226 FDA Orange Book
67 Europe
64 Canada
15 South Africa
37 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 4%, INJECTABLE;INJECTION - 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 20% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 4% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 0.005MG/ML;0.5%, INJECTABLE;INJECTION - 0.005MG/ML;1%, INJECTABLE;INJECTION - 0.005MG/ML;1.5%, INJECTABLE;INJECTION - 0.005MG/ML;2%, INJECTABLE;INJECTION - 0.01MG/ML;1%, INJECTABLE;INJECTION - 0.01MG/ML;2%, INJECTABLE;INJECTION - 0.02MG/ML;2%, INJECTABLE;INJECTION - 0.5%, INJECTABLE;INJECTION - 1%, INJECTABLE;INJECTION - 1.5%, INJECTABLE;INJECTION - 2%, INJECTABLE;INJECTION - 1%, INJECTABLE;INJECTION - 2%, INJECTABLE;INJECTION - 1%, INJECTABLE;SPINAL - 5%, JELLY;TOPICAL - 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 0.02MG BASE/ML;2%, INJECTABLE;INJECTION - EQ 0.01MG BASE/ML;2%

INJECTABLE;INJECTION - 4%
INJECTABLE;INJECTION - 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - 20% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - 4% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - 0.005MG/ML;0.5%
INJECTABLE;INJECTION - 0.005MG/ML;1%
INJECTABLE;INJECTION - 0.005MG/ML;1.5%
INJECTABLE;INJECTION - 0.005MG/ML;2%
INJECTABLE;INJECTION - 0.01MG/ML;1%
INJECTABLE;INJECTION - 0.01MG/ML;2%
INJECTABLE;INJECTION - 0.02MG/ML;2%
INJECTABLE;INJECTION - 0.5%
INJECTABLE;INJECTION - 1%
INJECTABLE;INJECTION - 1.5%
INJECTABLE;INJECTION - 2%
INJECTABLE;INJECTION - 1%
INJECTABLE;INJECTION - 2%
INJECTABLE;INJECTION - 1%
INJECTABLE;SPINAL - 5%
JELLY;TOPICAL - 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - EQ 0.02MG BASE/ML;2%
INJECTABLE;INJECTION - EQ 0.01MG BASE/ML;2%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Evonik, 6 Rochem International Inc, 12 SPI Pharma, 2 Seqens, 13 DKSH, 1 PMC Isochem, 1 Pharm-RX Chemical, 3 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 2 Gangwal Healthcare, 18 Nanjing Well Pharmaceutical, 1 Capital Farma, 1 ACG Worldwide, 22 Actylis, 3 Aeon Procare, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 43 BASF, 1 Bioplus Life Sciences, 1 BioSpectra, 1 Clariant, 17 Corel Pharma Chem, 3 Doshion Polyscience, 5 Finar, 13 Gangwal Chemicals, 4 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 18 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 9 Lubrizol Life Science Health, 9 Microlex e.U, 3 Nanjing Bold Chemical, 2 Nippon Fine Chemical, 2 Nomisma Healthcare, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 21 Roquette, 25 Seppic, 3 Shandong Focus Biotechnology Co., Ltd, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 4 Sigachi Industries, 3 The Dow Chemical Company, 2 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

75 Topical, 65 Solubilizers, 52 Coating Systems & Additives, 44 Thickeners and Stabilizers, 35 Parenteral, 35 Fillers, Diluents & Binders, 32 Controlled & Modified Release, 31 Emulsifying Agents, 26 Film Formers & Plasticizers, 22 Surfactant & Foaming Agents, 18 Granulation, 18 Taste Masking, 17 Direct Compression, 15 Rheology Modifiers, 14 Co-Processed Excipients, 10 Lubricants & Glidants, 10 API Stability Enhancers, 8 Chewable & Orodispersible Aids, 7 Disintegrants & Superdisintegrants, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Coloring Agents, 1 Soft Gelatin

75 Topical
65 Solubilizers
52 Coating Systems & Additives
44 Thickeners and Stabilizers
35 Parenteral
35 Fillers, Diluents & Binders
32 Controlled & Modified Release
31 Emulsifying Agents
26 Film Formers & Plasticizers
22 Surfactant & Foaming Agents
18 Granulation
18 Taste Masking
17 Direct Compression
15 Rheology Modifiers
14 Co-Processed Excipients
10 Lubricants & Glidants
10 API Stability Enhancers
8 Chewable & Orodispersible Aids
7 Disintegrants & Superdisintegrants
5 Empty Capsules
4 Vegetarian Capsules
4 Coloring Agents
1 Soft Gelatin

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 60 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
60 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 59 Finished Drug Prices

3 US Medicaid Prescriptions
59 Finished Drug Prices

MARKET PLACE

51 APIs, 15 FDF Dossiers

51 APIs
15 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 US Patents

4 US Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 1 Others

1 EDQM
1 USP
1 Others

$ API Ref.Price (USD/KG) : 18 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

4 All

01 3POWDER PHARMS

02 1THEA PHARMA

filter Patent Number Reset all filters

4 All

01 18540665

02 18759401

03 19358338

04 19370622

filter API Patent Reset all filters

4 All

01 4Blank

filter FDF Patent Reset all filters

4 All

01 1Y

02 3Blank

filter Expiration Date Reset all filters

4 All

01 12026-07-24

02 12029-10-22

03 12035-04-27

04 12035-09-28

LGM Lidocaine Hydrochloride

Product Main Page

01

POWDER PHARMS

LIDOCAINE HYDROCHLORIDE

BioAsia

Not Confirmed

POWDER PHARMS

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-09-28

LIDOCAINE HYDROCHLORIDE

US Patent Number : 9370622

Drug Substance Claim :

Drug Product Claim :

Application Number : 22114

Patent Use Code : U-1870

Delist Requested :

Patent Use Description : ZINGO IS A POWDER INTR...

Patent Expiration Date : 2035-09-28

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

POWDER PHARMS

LIDOCAINE HYDROCHLORIDE

BioAsia

Not Confirmed

POWDER PHARMS

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-04-27

LIDOCAINE HYDROCHLORIDE

US Patent Number : 9358338

Drug Substance Claim :

Drug Product Claim :

Application Number : 22114

Patent Use Code : U-1870

Delist Requested :

Patent Use Description : ZINGO IS A POWDER INTR...

Patent Expiration Date : 2035-04-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

POWDER PHARMS

LIDOCAINE HYDROCHLORIDE

BioAsia

Not Confirmed

POWDER PHARMS

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-10-22

LIDOCAINE HYDROCHLORIDE

US Patent Number : 8540665

Drug Substance Claim :

Drug Product Claim :

Application Number : 22114

Patent Use Code : U-1438

Delist Requested :

Patent Use Description : ZINGO INTRADERMAL INJE...

Patent Expiration Date : 2029-10-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

THEA PHARMA

LIDOCAINE HYDROCHLORIDE

BioAsia

Not Confirmed

THEA PHARMA

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-07-24

LIDOCAINE HYDROCHLORIDE

US Patent Number : 8759401

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22221

Patent Use Code : U-1523

Delist Requested :

Patent Use Description : METHOD OF INDUCING TOP...

Patent Expiration Date : 2026-07-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!